Journal Guide
Publishing in Clinical Infectious Diseases: Fit, Timeline & Submission Guide
Infectious disease: diagnosis, treatment, and epidemiology
Should you submit here?
Submit if present finding improving patient outcomes. Be careful if cID expects clinical significance.
7.3
Impact Factor (2024)
~25-35%
Acceptance Rate
~90-120 days median
Time to First Decision
Submission guide
Clinical Infectious Diseases Submission Guide: Scope, Format & Tips
Practical Clinical Infectious Diseases submission guide: what CID publishes, what editors screen for, and how to frame a clinically useful infectious.
Journal assessment
Is Clinical Infectious Diseases a Good Journal? Impact, Scope, and Fit
Clinical Infectious Diseases (IF 8.2, IDSA) is the flagship clinical infectious disease journal. Here's how it compares to Lancet ID, JID, and Clinical Microbiology Reviews.
Desk rejection
How to Avoid Desk Rejection at Clinical Infectious Diseases
How to avoid desk rejection at Clinical Infectious Diseases: what editors screen for and how to make the clinical consequence obvious.
What Clin. Infect. Dis. Publishes
Clinical Infectious Diseases published by Oxford University Press is the premier journal for clinical infectious disease research. With JIF 7.3 and Q1 ranking in Infectious Diseases, CID emphasizes rigorous clinical research on infection diagnosis, treatment, and outcomes. The journal publishes research on bacterial, viral, fungal, and parasitic infections. Critically: CID values research with clear clinical relevance and patient impact. Basic microbiology without clinical context is less competitive. The journal seeks papers advancing infection treatment and management.
- Bacterial infections: pneumonia, sepsis, endocarditis, meningitis
- Viral infections: HIV, influenza, COVID-19, viral hepatitis
- Fungal infections: invasive fungal disease, candidiasis, aspergillosis
- Parasitic infections: malaria, tuberculosis, neglected tropical diseases
- Antimicrobial resistance: resistance mechanisms, treatment strategies, surveillance
- Immunocompromised hosts: HIV/AIDS, transplant, cancer patients
- Infection prevention: vaccination, prophylaxis, infection control
- Epidemiology: disease transmission, outbreak investigation, risk factors
Editor Insight
“CID publishes clinical infectious disease advancing diagnosis and treatment. We seek rigorous studies with patient outcomes and clinical applicability.”
What Clin. Infect. Dis. Editors Look For
Clinical finding advancing infection diagnosis or treatment
Present finding improving patient outcomes. Better diagnostic test? Superior treatment? Prevention strategy? Show clinical impact with quantified benefits.
Rigorous clinical data with adequate patient cohort
Sufficient patient numbers and follow-up. Case series, cohort studies, or clinical trials with proper controls.
Mechanistic understanding of infection or treatment response
Explain mechanisms. Why does treatment work? What drives antibiotic resistance? What enables pathogenesis?
Patient outcomes and real-world clinical applicability
Show how findings affect patient outcomes. What does this mean for clinical practice?
Epidemiologic or public health significance
Address broader implications for disease control and population health.
Why Papers Get Rejected
These patterns appear repeatedly in manuscripts that don't make it past Clin. Infect. Dis.'s editorial review:
Basic microbiology without clinical relevance
CID expects clinical significance. Bacterial or viral studies without patient or treatment connection insufficient.
Small case series without rigorous statistical analysis
Case series valuable but need proper analysis. Multiple patients, clear clinical outcomes, appropriate controls.
No discussion of patient outcomes or clinical implications
Connect to clinical practice. How do findings change patient management?
Inadequate follow-up or outcome documentation
Sufficient follow-up showing outcomes essential. Short-term data without long-term assessment weak.
Ignoring antimicrobial resistance or treatment feasibility
Address resistance patterns and practical treatment considerations.
Does your manuscript avoid these patterns?
The Free Readiness Scan reads your full manuscript against Clin. Infect. Dis.'s criteria and flags the specific issues most likely to cause rejection.
Insider Tips from Clin. Infect. Dis. Authors
COVID-19 and emerging infection research highly competitive
Clinical research on emerging pathogens and pandemic preparedness receives strong interest.
Antimicrobial resistance and novel antibiotics valued
Resistance mechanisms and new treatment strategies addressing resistance increasingly important.
HIV/AIDS and immunocompromised host research trending
Infection in special populations (HIV, transplant) increasingly prominent.
Real-world evidence and outcomes research gaining importance
Practical treatment outcomes in diverse patient populations increasingly valued.
Diagnostic innovation and rapid testing competitive
Faster, better, cheaper diagnostics have clinical impact.
The Clin. Infect. Dis. Submission Process
Manuscript preparation
Prep5,000-8,000 words with 5-7 figures. Include patient cohort description, infection characterization, diagnostic or treatment data, outcomes, mechanistic discussion.
Submission via Oxford system
Day 0Submit at https://academic.oup.com/cid/. Required: manuscript emphasizing clinical significance, figures showing patient data and outcomes.
Editorial assessment
1-2 weeksEditor assesses clinical novelty and significance. Papers lacking clinical context face rejection. Moderate desk rejection ~25-35%.
Peer review
90-120 days2-3 infectious disease experts assess clinical rigor, significance, and outcomes. First decision 90-120 days.
Revision and publication
Revision: 4-8 weeksRevisions often request additional outcome data or clinical clarification. Publication 2-4 weeks after acceptance.
Clin. Infect. Dis. by the Numbers
| 2024 Impact Factor | 6.2 |
| 5-Year Impact Factor | 6.5 |
| Acceptance rate | ~25-35% |
| Desk rejection rate | ~25-35% |
| Median first decision | ~105 days |
| Open access option | $3,500 USD |
| Publisher | Oxford University Press |
| Founded | 1995 |
Before you submit
Clin. Infect. Dis. accepts a small fraction of submissions. Make your attempt count.
Start with the Free Readiness Scan. Unlock the Full AI Diagnostic for $29. If you need deeper scientific feedback, choose Expert Review. The full report is calibrated to Clin. Infect. Dis..
Article Types
Clinical Research
5,000-8,000 wordsInfectious disease research with clinical outcomes
Brief Report
2,500-4,000 wordsImportant clinical finding
Landmark Clin. Infect. Dis. Papers
Papers that defined fields and changed science:
- Antibiotic resistance treatment (various) - multidrug-resistant infections
- COVID-19 clinical trials (2020+) - pandemic therapeutics
- Immunocompromised host management (various) - opportunistic infections
Preparing a Clin. Infect. Dis. Submission?
Get pre-submission feedback from reviewers who've published in Clin. Infect. Dis. and know exactly what editors look for.
Run Free Readiness ScanNeed expert depth? See Expert Review Options
Primary Fields
Browse by Field
Related Journal Guides
- Publishing in The Lancet
- Publishing in JAMA (Journal of the American Medical Association)
- Publishing in Lancet Infectious Diseases
- Publishing in JAMA
- Publishing in RNA
Latest Journal-Specific Guides
- Submission guideClinical Infectious Diseases Submission Guide: Scope, Format & TipsPractical Clinical Infectious Diseases submission guide: what CID publishes, what editors screen for, and how to frame a clinically useful infectious.
- Journal assessmentIs Clinical Infectious Diseases a Good Journal? Impact, Scope, and FitClinical Infectious Diseases (IF 8.2, IDSA) is the flagship clinical infectious disease journal. Here's how it compares to Lancet ID, JID, and Clinical Microbiology Reviews.
- Desk rejectionHow to Avoid Desk Rejection at Clinical Infectious DiseasesHow to avoid desk rejection at Clinical Infectious Diseases: what editors screen for and how to make the clinical consequence obvious.
- Review timelineClinical Infectious Diseases Review Time: What Authors Can Actually ExpectCID now publishes unusually clear timing data, and the gap between desk-reject medians and reviewed-paper medians is the key thing authors need to understand.
More Guides for This Journal
- Acceptance rateClinical Infectious Diseases Acceptance Rate: What Authors Can UseClinical Infectious Diseases does not publish a strong official acceptance rate. The better submission question is whether the paper actually changes infectious-disease diagnosis, treatment, prevention, or management.
- Impact factorClinical Infectious Diseases Impact Factor 2026: Ranking, Quartile & What It MeansClinical Infectious Diseases impact factor is 7.3. Five-year JIF 7.2, Q1, rank 8/137. See comparisons and submission guidance.
- Publishing costsClinical Infectious Diseases APC and Open Access: Current OUP Pricing, Page Charges, and When Gold OA Is Worth ItClinical Infectious Diseases APC is USD 5,001, and page composition charges still apply. OUP hybrid model and route tradeoffs.
- Submission processClinical Infectious Diseases Submission Process: What Happens From Upload to First DecisionUse this Clinical Infectious Diseases submission process guide to understand editorial triage, reviewer routing, common delays, and what to tighten.
- Manuscript prepClinical Infectious Diseases Cover Letter: What Editors Actually Need to SeeClinical Infectious Diseases editors are screening for patient-management relevance, not just interesting pathogen data. A strong cover letter makes that consequence obvious fast.
- Publishing guideIs Clinical Infectious Diseases Indexed in PubMed? Yes, and MEDLINE Is ActiveClinical Infectious Diseases is indexed in PubMed and currently indexed for MEDLINE, which matters because infectious disease papers often need to reach clinicians, stewardship teams, and guideline readers quickly.
Ready to submit to Clin. Infect. Dis.?
A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what Clin. Infect. Dis. editors look for.
Avoid Desk Rejection
Get expert pre-submission review before you submit to Clin. Infect. Dis.. 3-7 day turnaround.
Manuscript Rejected?
Expert revision help to strengthen your manuscript and resubmit with confidence.
Reviewer Response Help
Get expert guidance crafting your response to Clin. Infect. Dis. reviewers.
Reference library
Compare Clin. Infect. Dis. with the broader publishing context
This journal guide is the best starting point for Clin. Infect. Dis.. The reference library covers the surrounding questions authors usually ask next: whether the package is ready, what drives desk rejection, how neighboring journals compare, and what the submission constraints look like across the field.
Checklist system / operational asset
Elite Submission Checklist
A flagship pre-submission checklist that turns journal-fit, desk-reject, and package-quality lessons into one operational final-pass audit.
Flagship report / decision support
Desk Rejection Report
A canonical desk-rejection report that organizes the most common editorial failure modes, what they look like, and how to prevent them.
Dataset / reference hub
Journal Intelligence Dataset
A canonical journal dataset that combines selectivity posture, review timing, submission requirements, and Manusights fit signals in one citeable reference asset.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Need field-expert depth? See Expert Review Options